You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brentuximab vedotin

Showing 51 - 75 of 296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell, Peripheral Trial in Czechia (Adcetris 50 MG Injection, Endoxan, Doxorubicin)

Not yet recruiting
  • Lymphoma, T-Cell, Peripheral
  • Adcetris 50 MG Injection
  • +4 more
  • Brno, Czechia
  • +6 more
Aug 26, 2021

Hodgkin Disease Trial in Belgium, France (Brentuximab Vedotin, Etoposide, Carboplatine)

Completed
  • Hodgkin Disease
  • Brentuximab Vedotin
  • +3 more
  • Bruxelles, Belgium
  • +18 more
Dec 6, 2021

Hodgkin Lymphoma Trial in United States (brentuximab vedotin, nivolumab)

Completed
Has Results
  • Hodgkin Lymphoma
  • Duarte, California
  • +12 more
Nov 3, 2021

Lymphatic Diseases Trial in Italy (Brentuximab Vedotin, Bendamustine)

Terminated
  • Lymphatic Diseases
  • Bologna, BO, Italy
  • +4 more
May 26, 2021

Hodgkin Lymphoma Trial in Worldwide (Doxorubicin, Bleomycin, Vinblastine)

Completed
  • Hodgkin Lymphoma
  • Antwerpen, Belgium
  • +64 more
Aug 18, 2022

Peripheral T-cell Lymphoma Trial in Worldwide (brentuximab vedotin, cyclophosphamide, doxorubicin)

Recruiting
  • Peripheral T-cell Lymphoma
  • brentuximab vedotin
  • +3 more
  • Birmingham, Alabama
  • +45 more
Jan 4, 2023

A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

Recruiting
  • Hodgkin Lymphoma
  • No Intervention
  • Wroclaw, Dolnoslskie, Poland
  • +14 more
Jun 23, 2022

Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin)

Completed
Has Results
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • Praha, Prague, Czechia
  • +17 more
Mar 10, 2021

AIDS-Related Hodgkin Lymphoma, Ann Arbor Stage II Hodgkin Lymphoma, Ann Arbor Stage IIA Hodgkin Lymphoma Trial in France, United

Active, not recruiting
  • AIDS-Related Hodgkin Lymphoma
  • +11 more
  • Brentuximab Vedotin
  • +4 more
  • La Jolla, California
  • +27 more
Jul 27, 2022

Germ Cell Tumor Trial in Minneapolis (Brentuximab Vedotin, Bevacizumab)

Terminated
Has Results
  • Germ Cell Tumor
  • Minneapolis, Minnesota
    University of Minnesota
Nov 12, 2020

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic Trial in China (Brentuximab Vedotin)

Completed
Has Results
  • Hodgkin Disease
  • Lymphoma, Large-Cell, Anaplastic
  • Brentuximab Vedotin
  • Beijing, Beijing, China
  • +6 more
Feb 3, 2021

Classical Hodgkin Lymphoma Trial in Cologne (Brentuximab Vedotin)

Recruiting
  • Classical Hodgkin Lymphoma
  • Brentuximab Vedotin
  • Cologne, Germany
    1st Department of Medicine, Cologne University Hospital
Nov 26, 2020

Relapsed or Refractory CD30+ Malignancies When Re-treated With

Completed
  • Hodgkin Disease
  • Lymphoma, T-Cell, Cutaneous
  • No Intervention
  • San Bartolome, Alicante, Spain
  • +29 more
Jul 28, 2022

Hodgkin Lymphoma Trial in France (brentuximab vedotin, Cyclophosphamide, Adriamycin)

Completed
  • Hodgkin Lymphoma
  • brentuximab vedotin
  • +9 more
  • Argenteuil, France
  • +29 more
Jul 23, 2021

CD30 Positive Primary Mediastinal Large B-cell Lymphoma, CD30-Positive DLBCL, CD30-Positive Gray Zone Lymphoma Trial in

Completed
Has Results
  • CD30 Positive Primary Mediastinal Large B-cell Lymphoma
  • +2 more
  • brentuximab vedotin
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 14, 2020

Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular

Recruiting
  • Ann Arbor Stage I Hodgkin Lymphoma
  • +13 more
  • Birmingham, Alabama
  • +16 more
Nov 23, 2021

Hodgkin Lymphoma, Adult Trial in Spain (Induction with Brentuximab vedotin (BV), Induction without Brentuximab Vedotin,

Recruiting
  • Hodgkin Lymphoma, Adult
  • Induction with Brentuximab vedotin (BV)
  • +2 more
  • Oviedo, Asturias, Spain
  • +18 more
Nov 28, 2020

Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)

Active, not recruiting
  • Hodgkin Disease
  • Nivolumab
  • +2 more
  • Birmingham, Alabama
  • +77 more
Jul 21, 2022

NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,

Recruiting
  • NK-Cell Lymphoma
  • +2 more
  • San Francisco, California
  • +1 more
Sep 1, 2021

Hodgkin Lymphoma Trial in Italy (Brentuximab Vedotin)

Completed
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • Brescia, BS, Italy
  • +5 more
Dec 21, 2020

Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large

Recruiting
  • Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

DLBCL Trial in Rotterdam (R-DHAP, Brentuximab Vedotin)

Recruiting
  • DLBCL
  • R-DHAP
  • Brentuximab Vedotin
  • Rotterdam, Netherlands
    NL-Rotterdam-ERASMUSMC
Dec 9, 2020

Advanced Hodgkin Lymphoma Trial in Worldwide (Brentuximab Vedotin, Adriamycin, Vinblastine)

Active, not recruiting
  • Advanced Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +6 more
  • Antwerp, Belgium
  • +18 more
May 4, 2022

Hodgkin Lymphoma Trial in Boston (Brentuximab Vedotin, Adriamycin, Dacarbazine)

Completed
Has Results
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 10, 2020

Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)

Active, not recruiting
  • Hodgkin Lymphoma
  • brentuximab vedotin
  • +5 more
  • Fountain Valley, California
  • +75 more
Dec 2, 2022